Tag: yte
Incyte (INCY) Gains FDA Nod for Monjuvi in Relapsed or Refractory Follicular Lymphoma (FL)
Incyte (INCY) announced that the U.S. Food and Drug Administration has approved Monjuvi® (tafasitamab-cxix), a humanized Fc-modified cytolytic CD19-targeting monoclonal antibody, for use in...